Omada Health, Inc. (NASDAQ: OMDA) President Shao Wei-Li forfeited 1,843 shares at $22.77 per share, leaving 299,349 shares after the transaction. The transaction took place on September 5, 2026.
Opus Genetics, Inc. (NASDAQ: IRD) is moving OPGx-BEST1 into higher-dose Cohort 2 at 4.5 x 10⁹ vg/eye after low-dose Cohort 1 produced clinically meaningful visual-function improvement in all five participants. The company said the early results also showed structural changes and a favorable safety …
OS Therapies Inc (AMEX: OSTX) secured approval for its amended and restated 2023 Incentive Compensation Plan with 4,515,930 votes in favor on September 9, 2026. Its stated purpose is to attract, motivate, retain and reward high-quality personnel while creating performance incentives tied toShareholdervalue.
MERIT MEDICAL SYSTEMS INC (NASDAQ: MMSI) awarded Lewis Sheri 8,371 shares at $0 per share. Sheri is the company’s executive vice president of Global Operations.
Nanobiotix S.A. (NASDAQ: NBTX) will participate in the H.C. Wainwright Annual Global Investment Conference on September 15, 2026. The company’s management will take part in a fireside chat, giving investors a scheduled opportunity to hear directly from its senior executives.
Nano-X Imaging Ltd. (NASDAQ: NNOX) reported an additional U.S. distribution agreement and a Costa Rica distribution agreement supporting continued expansion across Latin America while holding $31.023 million in cash at June 30, 2026. The balance stood at $49.151 million on December 31, 2025. The …
National Vision Holdings, Inc. (NASDAQ: EYE) Chief Technology Officer David Cutler exercised options covering 12,998 shares on Sep. 8, 2026. The transaction left him with 12,998 shares, representing about 100.0% of his resulting share holding.
W. P. Carey Inc. filed a Form 8-K with the SEC on September 10, 2026, disclosing its year-to-date investment volume and an improved outlook for 2026 tenant credit related rent loss via a press release issued the same day.
ElectroCore, Inc. (NASDAQ: ECOR) appointed Joshua S. Lev and Michael Fox as co-Chief Executive Officers and Presidents, setting both executives’ annual base salaries at $540,000. Lev will retain his role as Chief Financial Officer, while Fox will continue as Chief Operating Officer. The appointments …
After the transaction, Anjaneya held 178,947 derivative securities, while the award represented about 38.2% of that resulting holding.